SCHEMBL6875484

SCHEMBL6875484

COc1ccc(F)cc1CNCC1CCC(Nc2nccc(N(C)C)n2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.43
CYP2D6 P10635 1/20 0.43
GRIN2B Q13224 1/20 0.43
MCHR1 Q99705 5/20 0.43
ADRA2A P08913 2/20 0.43
NPY5R Q15761 1/20 0.43
HTR2A P28223 6/20 0.40
MAPK8 P45983 1/20 0.40
HTR2B P41595 6/20 0.39
HTR2C P28335 5/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
CDK1 P06493 1/20 0.38
CDK4 P11802 1/20 0.38
CCND1 P24385 1/20 0.38
CDK2 P24941 1/20 0.38
ADRA1A P35348 1/20 0.38
HRH1 P35367 1/20 0.38
ACHE P22303 1/20 0.38
DRD2 P14416 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6875477 1.00 KCNH2 (0.43) KCNH2CYP2D6GRIN2BMCHR1ADRA2A
SCHEMBL6875677 0.91 MCHR1 (0.41) KCNH2CYP2D6MCHR1ADRA2ANPY5R
SCHEMBL6875669 0.91 MCHR1 (0.41) KCNH2CYP2D6MCHR1ADRA2ANPY5R
SCHEMBL6876140 0.90 MCHR1 (0.42) MCHR1ADRA2ANPY5RMAPK8HTR2B
SCHEMBL6876132 0.90 MCHR1 (0.42) MCHR1ADRA2ANPY5RMAPK8HTR2B
SCHEMBL6880166 0.90 MCHR1 (0.49) MCHR1ADRA2ANPY5RACHEDRD2
SCHEMBL6464914 0.90 MCHR1 (0.49) MCHR1ADRA2ANPY5RACHEDRD2
SCHEMBL6873584 0.90 MCHR1 (0.42) KCNH2CYP2D6GRIN2BMCHR1ADRA2A
SCHEMBL6873577 0.90 MCHR1 (0.42) KCNH2CYP2D6GRIN2BMCHR1ADRA2A
SCHEMBL6880445 0.89 MCHR1 (0.43) KCNH2CYP2D6GRIN2BMCHR1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed